Below are the most recent publications written about "Vibrio cholerae" by people in Profiles.
-
Wang M, Du G, Yongo-Luwawa C, Lu A, Kinrade B, Munro K, Klose KE, Lubell WD, Davies P, Guo S. Peptide-based ligand antagonists block a Vibrio cholerae adhesin. FEBS Lett. 2026 Mar; 600(5):631-643.
-
Guo W, Zhang S, Park JH, Stanton V, Asp M, Herrera H, Tai JB, Yue J, Wang J, Guo J, Kumar R, Botting JM, Wu S, Yan J, Klose KE, Yildiz FH, Liu J. Structures of the sheathed flagellum reveal mechanisms of assembly and rotation in Vibrio cholerae. Nat Microbiol. 2025 Dec; 10(12):3305-3314.
-
Stanton V, Himes B, Mejia-Santana A, Eppinger M, Romo J, Xing J, Zhulin IB, Cai H, Wang Y, Inniss Nl, Minasov G, Satchell KJF, Klose KE. The PAS domain of the polarly localized histidine kinase FlrB in Vibrio cholerae controls class III flagellar transcription and contributes to intestinal colonization. mBio. 2025 Nov 12; 16(11):e0237925.
-
Gao N, Mazzoletti D, Peng A, Olinares PDB, Morrone C, Garavaglia A, Gouda N, Tsoy S, Mendoza A, Chowdhury A, Cerullo A, Bhavsar H, Rossi F, Rizzi M, Chait BT, Miggiano R, Jeruzalmi D. DnaB and DciA: mechanisms of helicase loading and translocation on ssDNA. Nucleic Acids Res. 2025 Jun 20; 53(12).
-
Finger F, Lemaitre J, Juin S, Jackson B, Funk S, Lessler J, Mintz E, Dely P, Boncy J, Azman AS. Inferring the proportion of undetected cholera infections from serological and clinical surveillance in an immunologically naive population. Epidemiol Infect. 2024 Dec 02; 152:e149.
-
Sherik M, Eves R, Guo S, Lloyd CJ, Klose KE, Davies PL. Sugar-binding and split domain combinations in repeats-in-toxin adhesins from Vibrio cholerae and Aeromonas veronii mediate cell-surface recognition and hemolytic activities. mBio. 2024 Feb 14; 15(2):e0229123.
-
Lloyd CJ, Guo S, Kinrade B, Zahiri H, Eves R, Ali SK, Yildiz F, Voets IK, Davies PL, Klose KE. A peptide-binding domain shared with an Antarctic bacterium facilitates Vibrio cholerae human cell binding and intestinal colonization. Proc Natl Acad Sci U S A. 2023 09 26; 120(39):e2308238120.
-
Richardson S, Medhavi F, Tanner T, Lundy S, Omosun Y, Igietseme JU, Carroll D, Eko FO. Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine. Front Immunol. 2021; 12:698737.
-
Zuo Z, Zou Y, Li Q, Guo Y, Zhang T, Wu J, He C, Eko FO. Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge. Sci Rep. 2021 05 17; 11(1):10389.
-
Howard S, Richardson S, Benyeogor I, Omosun Y, Dye K, Medhavi F, Lundy S, Adebayo O, Igietseme JU, Eko FO. Differential miRNA Profiles Correlate With Disparate Immunity Outcomes Associated With Vaccine Immunization and Chlamydial Infection. Front Immunol. 2021; 12:625318.